EMERGENT BIOSOLUTIONS INC (EBS)
US29089Q1058 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -760.50M | -223.80M | 230.90M | 305.10M | 54.50M | |||
| Depreciation Amortization | 125.10M | 143.30M | 123.80M | 114.50M | 110.70M | |||
| Income Taxes - Deferred | -8.90M | -19.00M | 46.90M | -2.40M | -1.10M | |||
| Change In Working Capital | -75.10M | -30.70M | -156.40M | 8.80M | -42.40M | |||
| Interest Paid | 68.30M | 33.00M | 30.40M | 21.00M | 34.50M | |||
| Taxes Paid | 52.80M | 6.20M | 71.60M | 109.30M | 30.80M | |||
| Other non cash items | 513.10M | 64.90M | 75.90M | 110.00M | 66.30M | |||
| OPERATING CASH FLOW | -206.30M | -34.10M | 321.10M | 536.00M | 188.00M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -57.90M | -359.50M | -225.00M | -151.00M | -96.90M | |||
| Other Investing Activity | 270.20M | -21.80M | N/A | N/A | 0.00 | |||
| INVESTING CASH FLOW | 212.30M | -381.30M | -225.00M | -151.00M | -96.90M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -543.40M | 564.20M | -35.90M | 62.90M | 13.70M | |||
| Stock Issued/Repurchased | 10.20M | -77.10M | -90.10M | 31.60M | 8.20M | |||
| Other Financing Activity | -2.50M | -5.90M | -15.00M | -25.00M | -57.80M | |||
| FINANCING CASH FLOW | -535.70M | 481.20M | -141.00M | 69.50M | -35.90M | |||
| Exchange Rate Effect | -1.20M | 500.00K | -300.00K | -1.00M | 400.00K | |||
| CHANGE IN CASH | -530.90M | 66.30M | -45.20M | 453.50M | 55.60M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -206.30M | -34.10M | 321.10M | 536.00M | 188.00M | |||
| Capital Expenditure | -57.90M | -359.50M | -225.00M | -151.00M | -96.90M | |||
| FREE CASH FLOW | -264.20M | -393.60M | 96.10M | 385.00M | 91.10M | |||
All data in USD